Peter J. Flowers presents updates on the Stryker Rejuvenate and Stryker V40 litigation at the HarrisMartin's MDL Conference
Peter J. Flowers, a partner at Meyers & Flowers, recently provided updates on the Stryker Rejuvenate and Stryker V40 litigation at the HarrisMartin's MDL Conference: Orthopedic Devices and Hernia Mesh Litigation Conference held in Boston.
HarrisMartin is a leading provider of litigation news and presents a series of highly respected legal conferences. Mr. Flowers joined his colleagues to speak about on-going developments in the two mass tort cases.
Mr. Flowers is Co-Lead Counsel of the Plaintiffs’ Executive Committee for the Stryker LFIT V40 Femoral Head Products Liability Litigation (Boston-based MDL 2768). The Stryker LFIT Anatomic V40 Femoral Head was recalled by the FDA in 2016 in what may end up being one of the largest hip replacement device recalls of the last decade. More than 40,000 of these devices were manufactured and potentially implanted in hip replacement patients in the US and worldwide.
He also serves as the Multidistrict Litigation Plaintiffs’ Lead Counsel Committee Chair for the multidistrict product liability litigation against Stryker Corporation and Howmedica Osteonics Corp for the companies’ Stryker Modular Rejuvenate and ABG II Femoral Hip Implants. He is representing thousands of patients affected and injured by the hip replacement device. His work on the committee led to a global medical device settlement with an unlimited compensation fund for the victims of the defective hip implants.
The Meyers & Flowers team has a long history and extensive expertise in defective metal-on-metal hip replacement litigation. Their dedication to pursuing justice for those hurt or impacted by defective medical devices and pharmaceuticals has helped tens of thousands of patients and countless family members.